Cargando…
A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophage...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536709/ https://www.ncbi.nlm.nih.gov/pubmed/31213896 http://dx.doi.org/10.2147/CMAR.S204938 |
_version_ | 1783421821002973184 |
---|---|
author | Fan, Ningbo Chen, Dongni Zheng, Jiabo Wen, Zhesheng Lin, Peng |
author_facet | Fan, Ningbo Chen, Dongni Zheng, Jiabo Wen, Zhesheng Lin, Peng |
author_sort | Fan, Ningbo |
collection | PubMed |
description | Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ(2)=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ(2)=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ(2)=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. |
format | Online Article Text |
id | pubmed-6536709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-65367092019-06-18 A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio Fan, Ningbo Chen, Dongni Zheng, Jiabo Wen, Zhesheng Lin, Peng Cancer Manag Res Original Research Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ(2)=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ(2)=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ(2)=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Dove 2019-05-23 /pmc/articles/PMC6536709/ /pubmed/31213896 http://dx.doi.org/10.2147/CMAR.S204938 Text en © 2019 Fan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Fan, Ningbo Chen, Dongni Zheng, Jiabo Wen, Zhesheng Lin, Peng A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title_full | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title_fullStr | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title_full_unstemmed | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title_short | A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
title_sort | novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536709/ https://www.ncbi.nlm.nih.gov/pubmed/31213896 http://dx.doi.org/10.2147/CMAR.S204938 |
work_keys_str_mv | AT fanningbo anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT chendongni anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT zhengjiabo anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT wenzhesheng anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT linpeng anovelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT fanningbo novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT chendongni novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT zhengjiabo novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT wenzhesheng novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio AT linpeng novelpreoperativeplasmaindicatortopredictprognosesforpatientswithesophagealsquamouscellcarcinomaafterradicalesophagectomyfibrinogentolymphocyteratio |